BIOTRICITY INC by Biotricity Inc. (BTCY) Stock Price, Quote, News & History | Benzinga

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD81,437.11−0.37%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

BIOTRICITY INC by Biotricity Inc. (BTCY) Stock Price, Quote, News & History

BTCYOTCQB

Trade with Public

Trade with Public

$0.0447

-0.42-90.35%

Last update: Oct 12, 3:46 PM

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare

Key Statistics

Open

-

Close

-

Volume / Avg.

26.17K / 35.97K

Day Range

- - -

52 Wk Range

0.04 - 0.75

Market Cap

-

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

Recent Biotricity Inc News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Avi Kapoor

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Avi Kapoor

Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.

Lisa Levin

Partner Content

Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology

The integration of AI technology in healthcare has revolutionized the industry, particularly in the areas of automation, big data analytics, and optimization. AI-powered software is designed to assist healthcare workers by performing tasks that are time-consuming and require high levels of accuracy.

Biotricity Predicted To Achieve 44% Annual Growth Despite Market Risks, Analyst Says

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

161.66K

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

-68.90K

Free Cash Flow (TTM)

161.66K

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

92.76K

Valuation Metrics

Enterprise Value

$31.66M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.08

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-251.43%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

21.59

Price / EBITDA (TTM)

0.95

Price / Free Cash Flow (TTM)

8.61

Book Value / Share

-$1.89

Company Debt

Total Debt

$26.68M

LT Debt

$870.80K

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$466.50K

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-